Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CYTOGAM
- CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
- CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients
- Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
- Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection
- A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
- Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation
- Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients
- Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
- The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease
- Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
Clinical trials list
click for details